ArticleJournal of diabetes research2025

SGLT2 Inhibitor and GLP-1 Receptor Agonist Prescriptions in Newly Diagnosed Type 2 Diabetes Patients With Cardiorenal Risks: A Cross-Sectional Study.

Frank Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.